Dermatologic Conditions in Transgender Populations

Yeung, Howa; Kahn, Benjamin; Ly, Bao Chau; Tangpricha, Vin

doi:10.1016/j.ecl.2019.01.005

Cited by 33 publications

(76 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Male pattern hair loss usually occurs within a few years after GHT initiation. 12 A prospective study in 20 TM showed that only one TM developed male pattern hair loss within 1 year after testosterone treatment. 13 Concurrently, the 1-year incidence was 17% in another study of 53 TM.…”

Section: Discussionmentioning

confidence: 99%

Effects of testosterone treatment on transgender males: A single-institution study

et al. 2021

View full text Add to dashboard Cite

Objectives: Data regarding gender-affirming hormone therapy in the Asian population are sparse. We aimed to evaluate the efficacy and safety of testosterone therapy in transgender men. Methods: A retrospective study chart review was conducted in a single university-based transgender clinic. Transgender men aged >18 years who newly started testosterone therapy during January 2015 to October 2019 were recruited. Physical changes, laboratory results, and adverse events, including cancer, thromboembolism, cardiovascular events, and death after masculinizing hormone therapy, were evaluated. Results: A total of 39 transgender men (mean age: 27.8 ± 6.0 years) were included. All individuals were treated with intramuscular testosterone injection with a mean follow-up of 25.2 ± 12.9 months. The most common maintenance regimen was testosterone enanthate 250 mg every 4 weeks. Masculinizing effects developed in all transgender men. There were no changes in body weight, and systolic and diastolic blood pressure. Hematocrit levels were 12% significantly increased from 39.9 ± 3.3% to 48.9 ± 2% (p < 0.001). Ten individuals (25.6%) had hematocrit >50%. Significant changes were found in decreased fasting plasma glucose, increased creatinine, and increased uric acid levels. A non-significantly increased alanine aminotransferase, increased low-density lipoprotein cholesterol, and decreased high-density lipoprotein cholesterol were observed. No thromboembolism, cancer, stroke, or coronary artery disease occurred. Conclusions: Gender-affirming hormone therapy is an effective and safe short-term treatment in Thai transgender men. Apart from the standard recommendation, uric acid, plasma glucose, and creatinine level evaluation before and during masculinizing hormone therapy are rational practices. An intramuscular testosterone enanthate 250 mg every 4 weeks is an alternative masculinizing regimen with decent efficacy and safety profile.

show abstract

Section: Discussionmentioning

confidence: 99%

Effects of testosterone treatment on transgender males: A single-institution study

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Secondary sex characteristic care is preventative care. Trans people's mental and physical health, including prevention of violence, can only be addressed when they can access gender‐affirming care, which provides relief from body dysphoria, depression, and anxiety, 19,21 thus resulting in fewer psychotherapy, urgent care, and emergency needs. Trans feminine people who obtain care that helps them to pass as cisgender women, if this is their goal, are less likely to experience violence 20 .…”

Section: Benefits Of Gender Carementioning

confidence: 99%

Missing Ethical Discussions in Gender Care for Transgender and Non‐binary People: Secondary Sex Characteristics

Rabelais

2020

J Midwife Womens Health

View full text Add to dashboard Cite

The inclusion of care for transgender and non-binary people in midwifery and women's health care is affirming to communities that have long been cast as outsiders. The recent discussions in this journal of care for trans feminine 1 and trans masculine 2 individuals, the 2018 editorial on "gender-neutral" language, 3 and the updated American College of Nurse-Midwives Core Competencies for Basic Midwifery Practice 4 are heartening, although the latter falls behind in naming and describing both gender care and its competencies. As this journal's editors mention, language is important and evolves; the same goes for ethical discussions of all care, but in particular for those communities that experience multiple social and political marginalizations. Midwifery and women's health clinicians' longstanding support for women can and should become inclusive of support for transgender and non-binary communities (henceforth collectively referred to as trans, as non-binary conceptually falls under the trans umbrella). Gender and transition care affirm one's gender and gendered needs, including mental health and physical appearance. This commentary assumes informed consent access to gender and transition care 5 and concentrates on the missing ethical discussions of secondary sex characteristics as a necessary focus for clinical care for trans people to optimize their health and reduce their risk of experiencing anti-trans violence. The purpose of this commentary is to establish an ethical starting place for the discussion of where clinicians should direct their attention and how to shape their actionoriented responses in the care of secondary sex characteristics for trans individuals. Trans feminine secondary sex characteristic needs are the focus of this commentary, because the majority of anti-trans violence is perpetuated against trans women. 6-8 An important concept related to this violence is passing, which means having a gender appearance that is expected by either the trans individual themself or others viewing the trans person. For example, a trans woman who is passing would have a physical appearance that conforms to societal expectations of a cisgender woman's appearance, including hairlessness in locations such as the face. 6 Trans peo

show abstract

“…Research regarding transgender health has dramatically increased, yet there is still significant room for improvement as TGNC individuals are at an increased risk for several health issues (Reisner et al, 2016 ; Ackerley et al, 2019 ; Neblett and Hipp, 2019 ; Yeung et al, 2019 ; Wiepjes et al, 2020 ). A gender inclusive approach in biomedical research is vital to our understanding and treatment of TBI.…”

Section: Introductionmentioning

confidence: 99%

Sex, Genes, and Traumatic Brain Injury (TBI): A Call for a Gender Inclusive Approach to the Study of TBI in the Lab

Duncan

Garijo-Garde

2021

Front. Neurosci.

View full text Add to dashboard Cite

Dermatologic Conditions in Transgender Populations

Cited by 33 publications

References 56 publications

Effects of testosterone treatment on transgender males: A single-institution study

Effects of testosterone treatment on transgender males: A single-institution study

Missing Ethical Discussions in Gender Care for Transgender and Non‐binary People: Secondary Sex Characteristics

Sex, Genes, and Traumatic Brain Injury (TBI): A Call for a Gender Inclusive Approach to the Study of TBI in the Lab

Contact Info

Product

Resources

About